Both in R&D — Physical & Biological Sciences
NRC Health vs MaxCyte
Over the past year NRC returned +75.1% and MXCT returned +9.0%; their daily moves had a correlation of 0.14.
NRC +75.1% MXCT +9.0%Growth of $1, one year, split-adjusted
| Metric | NRC | MXCT |
|---|---|---|
| Price | $23.20 | $1.69 |
| Market cap | $513.2M | $174.4M |
| Today | +6.67% | +9.74% |
| 1 month | +10.2% | +43.2% |
| 6 months | +40.3% | +106.7% |
| Year to date | +23.6% | +9.0% |
| 1 year | +103.2% | +9.7% |
| Revenue growth (YoY) | +4.0% | −14.5% |
| Gross margin | 61.7% | 77.0% |
| Net margin | −9.3% | −122.0% |
| P/E (TTM) | 92.4× | — |
| Price / sales | 3.7× | 5.6× |
| Net cash | -$86.7M | $105.7M |
| Dividend yield | 2.76% | — |
| Volatility (60d) | 44.8% | 78.2% |
| Short % of float | 7.2% | 2.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).